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ABSTRACT
Background and Objectives: A persistent problem in
operative laparoscopy is the removal of laparoscopically
resected tissue specimens. This study is a consecutive
series demonstrating a device designed to facilitate the
removal of laparoscopically resected tissue specimens.
Methods: Forty-two patients met the criteria for inclusion
in this study. These patients included gynecologic opera-
tive laparoscopy patients with a laparoscopically resected
tissue specimen placed in a tissue retrieval sac. The sac
could not to be removed from a subumbilical trocar inci-
sion with axial traction. The device was placed and an
attempt was made to remove the sac/specimen. When
successful, the wound was inspected for a fascial defect
and closed, and if unsuccessful the wound was enlarged
to remove the tissue specimen.
Results: Thirty-four patients had successful removal of the
laparoscopic tissue specimen. In 8 patients, the device was
not successful. No adverse intraoperative outcomes oc-
curred. Three patients had superficial postoperative wound
infection treated successfully with outpatient oral antibiotic
therapy. There were no other postoperative complications.
Conclusion: This novel medical device allows an easy
and effective means to remove trapped laparoscopic tis-
sue retrieval sacs. Prudent use of this device appears to
convey no increased risk of adverse surgical outcomes.
Key Words: Laparoscopic tissue retrieval device, Laparo-
scopic tissue retrieval sac.
INTRODUCTION
Operative laparoscopic surgery has expanded its bound-
aries exponentially over the past 2 decades. In this regard,
laparoscopic surgeons continue to face one persistent
problem. This problem is the ability to safely and effec-
tively remove a variety of laparoscopically resected tissues
from the abdominal cavity. Of course, one solution to this
problem is to enlarge one of the laparoscopic trocar inci-
sions to remove the tissue specimen intact. This solution
is, however, counterproductive to the concept of mini-
mally invasive surgery. Another solution is to morcellate
the specimen with some type of morcellation device.
Morcellation, however, is not acceptable in many surgical
cases, because of the risk of dissemination of infection
and/or malignant neoplasia. Also, morcellation may com-
promise adequate pathologic examination of the resected
tissue specimen.
Several laparoscopic tissue retrieval sacs exist to facilitate
removal of intact surgical tissue specimens (eg, E-Sac,
ENDO CATCH™, Pleatman Sac®, Endobag®). Though
these sacs are very effective in isolating a surgical speci-
men from the peritoneal cavity and the abdominal inci-
sion, they all have one inherent disadvantage. This disad-
vantage is that they distend as the tissue inside of them is
brought up to the interior aspect of the abdominal wall in
preparation for removal from the abdominal cavity. The
specimen becomes trapped in the abdominal cavity if
the diameter of the distended sac becomes larger than the
diameter of the incision. A variety of maneuvers can be
attempted using traditional surgical instrumentation to fa-
cilitate the removal of these laparoscopically resected tis-
sue specimens with variable success. In many cases, a
laparoscopic surgeon is frustrated by either rupturing the
laparoscopic retrieval sac or enlarging an otherwise small
incision. Ghezzi et al1 recently published the only study
that showed that large gynecologic masses could be safely
and successfully removed by morcellation of the masses
in the laparoscopic tissue retrieval sac through a standard
10-mm trocar incision.
With the above considerations in mind, a device is needed
to counteract the physical constraints of small incisions
and the physical characteristics of a laparoscopic tissue
retrieval sac. First, such a device should minimize the
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SCIENTIFIC PAPERdiameter of the laparoscopic tissue retrieval sac and the
enclosed surgical specimen. Second, the device should
help protect the integrity of the sac/surgical specimen.
Third, it should facilitate removal of the sac/surgical spec-
imen by allowing axial traction to be applied to the device
and not the sac/surgical specimen. Such a device has been
developed by Schellpfeffer.2-4 It is patterned after an ob-
stetrical forceps5 and fulfills all of the above requirements.
Recently, Brown et al6 confirmed this concept, demon-
strating that standard obstetrical forceps can be used to
extract nephrectomy specimens enclosed in a laparo-
scopic retrieval sac. As illustrated in Figure 1a, the device
consists of a left and right side. Each side has a handle, a
shank, a portion of the locking mechanism, and a blade.
Each blade’s width is 2cm. The device freely articulates
and disarticulates to allow for placement around a sac/
specimen (Figure 1b). The size and curve of the blades
allow for easy introduction of each portion of the device
around the laparoscopic tissue retrieval sac/specimen
through a standard incision made for a 10/12-mm trocar.
Once applied to the sac/specimen, the device minimizes
the diameter of the sac/specimen and protects its integrity.
Axial traction is then applied to the device to facilitate
removal of the sac/specimen.
The purpose of this study was to demonstrate the useful-
ness of this newly developed laparoscopic tissue retrieval
device in removing trapped surgical tissue specimens re-
sected at the time of operative gynecologic surgery.
MATERIALS AND METHODS
This study was a consecutive series of patients over a
5-year period all operated on by the author. The inclusion
criteria for this study were as follows:
1) a laparoscopically resected tissue specimen placed
within a laparoscopic tissue retrieval sac not able to be
removed from the abdominal cavity by axial traction on
the sac.
2) all of the extractions were performed through a sub-
umbilical trocar incision that had previously accommo-
dated a standard 10/12-mm disposable laparoscopic tro-
car without enlarging the incision.
3) no cases of obvious malignant or grossly infected sur-
gical tissue specimens were included in this study.
Forty-two operative gynecologic laparoscopic procedures
were performed that met the criteria of this study. All
surgical procedures were performed by the author, and
the study was approved by the hospital Institutional Re-
view Board.
Extraction Procedure
The extraction procedure begins after an unsuccessful
attempt at removal of the laparoscopic tissue extraction
sac and the enclosed tissue specimen through the subum-
bilical incision site after removal of the trocar. The sac/
specimen is directly visualized using a 5-mm laparoscope
placed through a previously placed lower abdominal
5-mm accessory port. Direct laparoscopic visualization of
the sac/specimen and the forceps placement is performed
continuously throughout the extraction process. Figures
2 through 4 demonstrate the application of the device to
a laparoscopic tissue retrieval sac/specimen, and removal
Figure 1. The laparoscopic tissue retrieval forceps is seen (a)
assembled and (b) disassembled.
A Novel Laparoscopic Tissue Retrieval Device, Schellpfeffer MA.
JSLS (2011)15:527–532 528of the sac/specimen from the abdominal cavity. Figure 2
and 3 show an exterior view of the placement of the right
and left blade, respectively. Figure 4 illustrates the 2
blades locked in place around the sac/specimen with
traction being applied for removal from the abdominal
cavity. After removal of the sac/specimen, the trocar inci-
sion site is inspected to identify any possible extension of
the trocar incision fascial defect that may have occurred as
a result of placement of the device or removal of the
sac/specimen. The fascial defect from the subumbilical
trocar is then closed with interrupted synthetic delayed
absorption sutures. Postoperatively, all of the patients are
seen for a routine postoperative examination between 2
weeks to 6 weeks after the surgery. All patients are que-
ried and examined for any adverse outcomes. Long-term
outcomes are obtained if possible.
RESULTS
Of the 42 patients included in this study, 34 had successful
removal of the laparoscopic tissue retrieval sac and surgi-
cal specimen. Table 1 lists the procedures performed and
the outcomes. In 8 patients (19%), the sac/specimen was
unable to be removed successfully. All of the unsuccessful
cases were related to the size of the tissue to be removed.
In these cases, the subumbilical incision was enlarged,
and the specimen was removed successfully. There were
no sac ruptures. All of the specimens were removed
intact for standard pathologic examination. Tissue volumes
were provided from the pathology reports. Several spec-
imens were drained inside the laparoscopic retrieval sac,
and one specimen was divided due to its size prior to
placement in a sac. There were no other intraoperative
adverse outcomes among the study population. Postop-
eratively, 3 patients (7%) had superficial subumbilical
trocar-site wound infections. Each of the infections
responded quickly and completely to oral antibiotic ther-
apy. One patient had postoperative urinary retention re-
quiring continuous bladder catheterization for 24 hours.
Two patients, done on an emergent basis, failed to follow
up for postoperative visits and were lost to follow-up. In
the short-term follow-up over a 2-week to 6-week period,
there were no incisional hernias in the study population
patients who returned for follow-up examinations. There
were no other postoperative complications as a result of
the use of the device in this study population. Fifteen of 42
patients (35.7%) were seen in long-term follow-up from 6
months to 5 years. There were no long-term adverse
outcomes as a result of the use of the device.
DISCUSSION
This study showed that this novel medical device is po-
tentially both efficacious and safe to use in facilitating the
removal of trapped laparoscopically resected tissue spec-
imens. By design, this study demonstrated the efficacy of
the forceps in that the major criteria for entry into the
study was the inability to remove the tissue retrieval sac/
specimen from the abdominal cavity with ordinary axial
traction on the retrieval sac. Over 80% of the trapped
Figure 3. The left forceps blade (upper blade) is placed along-
side of the tissue retrieval sac. The left forceps blade is placed in
between the right blade and the retrieval sac.
Figure 2. The right forceps blade (lower blade) is placed along
side of the tissue retrieval sac. The retrieval sac is always ori-
ented anterior or in front of the blade placement.
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ing the forceps. The majority of the forceps failures were
due to the size of the tissue specimen. The safety of the
device was also demonstrated in that there were no major
complications observed as a result of using the forceps.
The postoperative infections were all minor and well
within the range of current reports of infectious compli-
cations for operative gynecologic laparoscopy.7-9 Long-
term follow-up in greater than a third of the patients also
demonstrated no adverse outcomes from use of the de-
vice.
There are, however, several points that need to be
emphasized in using this device. First, it is imperative
that the device placement, locking, and extraction pro-
cess continually be observed through the laparoscope
as it is performed to avoid any possible injury to the
intraabdominal organs. Injury to intraabdominal organs
is also prevented by maintaining an adequate pneumo-
peritoneum. This is facilitated by holding the tissue
extraction sac in close apposition to the inferior aspect
of the anterior abdominal wall during the forceps place-
ment. Secondly, to allow for quick and easy placement
and locking of the device, proper initial orientation of
the instrument is essential. The extraction sac must
always be kept anterior or in front of the blade place-
ment. The device itself should always be assembled
outside the abdomen with the locking pin of the right
blade facing up and the left blade label “L” facing up.
Each blade is then introduced separately. The right or
bottom blade is placed first beneath or posterior to the
anteriorly oriented extraction sac. Then the left or top
blade is placed between the right blade handle and the
anteriorly oriented extraction sac. This procedure will
ensure that the blades will always be oriented correctly
around the specimen for easy and effective locking and
extraction. Finally, the trocar site used for the extraction
must be inspected to ensure that the fascial defect is
properly closed. On occasion, the fascial defect is en-
larged during the extraction process. As long as the
entire extent of the fascial defect is identified, it is easily
closed in the routine fashion as is done with any other
trocar site 10mm as recommended by Kadar et al.10
It appears that use of this device conveys no significant
additional risk, and it does allow the laparoscopic sur-
geon another means to facilitate removal of laparo-
scopically resected tissue specimens. Prudent use of
this device is, however, imperative. Following the gen-
eral guidelines recommended for performance of safe
operative laparoscopic surgery is still paramount. As
general use of this device increases, continued moni-
toring and re-assessment of its capabilities and potential
ultimate limitations is also important. Certainly a larger
cohort of patients needs to be studied to confirm the
efficacy and safety of this device. Future clinical uses
for this device could include its use in a wider range of
laparoscopic surgeries. Prototypes are already under
development for larger versions of the device to allow
bigger laparoscopic tissue retrieval sacs and specimens
to be removed through mini-laparotomy type incisions.
Smaller prototypes are also in development for use in
pediatric operative laparoscopic cases.
CONCLUSIONS
This laparoscopic tissue retrieval device is a novel medical
device that allows an easy and effective means to remove
trapped laparoscopic tissue retrieval sacs with enclosed
tissue specimens.
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Procedures and Outcomes
Patient Age Weight Clinical Indication
a Procedure
a Pathology Tissue Volume
(cc)
Outcome Complications
1 45 159 Pelvic Pain/Mass LSO Hydrosalpinx 25 Successful None
d
2 40 147 Complex Pelvic Mass LSO Hydrosalpinx 15
b Successful LTF
3 47 148 Pelvic Pain S/P Hyst BSO Hem. C-L Cysts L-35/R-31.5 Successful None
4 54 166 Complex Pelvic Mass BSO Serous Cystadenoma L-42/R-18 Failed None
d
5 34 117 Pelvic Pain LSO Endometrioma 36.7 Successful None
d
6 81 173 Postmenopausal Mass LSO Serous Cystadenoma 30 Successful None
7 44 187 Complex Pelvic Mass LSO Serous Cystadenoma 168 Successful None
d
8 72 144 Postmenopausal Mass LSO Serous Cystadenoma 9.5 Successful None
9 34 165 Complex Pelvic Mass L Cyst Benign Cystic Teratoma 8.2 Successful None
d
10 45 150 Pelvic Pain/Mass LSO Serous Cystadenoma 34.9 Failed None
11 74 107 Postmenopausal Mass BSO Ovarian Fibroma R-2.8/L-22.8 Successful None
12 30 161 Pelvic Pain/Mass RSO Hem. C-L Cyst 8.4 Successful None
13 33 202 Acute Pelvic Pain LSO Adnexal Torsion 523 Failed None
14 44 202 Pelvic Pain/Mass BSO Endometrioma R-13.4/L-10.9 Successful None
d
15 46 199 Pelvic Pain S/P Hyst BSO Normal T/O 56 Successful None
16 54 155 Postmenopausal Mass BSO Benign Cystic Teratoma 6.7
b Successful None
d
17 67 175 Postmenopausal Mass BSO Serous Cystadenoma R-3.1/L-5.2 Successful SWI
d
18 49 188 Pelvic Pain/Mass RSO C-L Cyst 48 Successful SWI
19 34 194 Pelvic Pain/Mass LSO TOA 96 Failed None
20 34 184 Acute Pelvic Pain LSO Torsed Cystadenoma 256
c Successful None
d
21 38 158 Pelvic Pain/Mass RSO Serous Cystadenoma 8 Successful None
22 42 112 Pelvic Pain/Mass BSO Paratubal Cyst L-28/R-35 Successful None
23 34 337 Complex Pelvic Mass L Cyst Benign Cystic Teratoma 22.4
b Successful None
d
24 60 197 Postmenopausal Mass LSO Hydrosalpinx 33.5 Successful None
25 45 207 Metastatic Breast CA BSO Normal T/O 38.4 Successful None
26 25 150 Chronic PID BS Hydrosalpinx 14.5 Successful None
d
27 55 227 Postmenopausal Mass BSO Serous Cystadenoma L-113/R-6
b Successful None
28 46 158 Leiomyoma Uteri BSO w/VH Normal T/O 22.4 Successful None
d
29 39 200 Pelvic Pain/Mass RSO Hem. C-L Cyst 17.5 Successful None
30 40 140 Pelvic Pain/Mass RSO Hydrosalpinx 12 Successful None
31 53 176 Pelvic Pain/Mass BSO Serous Cystadenoma R-19.9/L-16.6 Successful None
d
32 40 N/A Acute Pelvic Pain LSO Torsed Hydrosalpinx 121 Failed LTF
33 48 194 Familial Ovarian CA BSO Normal T/O 22.3 Successful None
d
34 17 166 Pelvic Pain/Mass L Cyst Benign Cystic Teratoma 9.4 Successful None
35 50 148 Pelvic Pain/Mass BSO Hem. C-L Cyst 33.5 Successful PUR
d
36 38 173 Pelvic Pain/Mass RO C-L Cyst 10 Successful None
37 54 130 Post menopausal Mass LSO Serous Cystadenoma 68.2
b Successful None
38 69 227 Postmenopausal Mass BSO Lipoleiomyoma R-3.5L-64.7 Failed None
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Table 1. Continued
Procedures and Outcomes
Patient Age Weight Clinical Indication
a Procedure
a Pathology Tissue Volume
(cc)
Outcome Complications
39 54 240 Postmenopausal Mass RO Benign Cystic Teratoma 351
b Failed None
40 45 149 L Pelvic Mass LO Benign Cystic Teratoma 22.4
b Success None
41 42 154 Bil Pelvic Masses Bil Cyst Benign Cystic Teratoma R-28.1/L-7 Failed None
42 43 147 L Pelvic Mass L Cyst L Peritubal Cyst 8.2 Success None
aLSOleft salpingo-oophorectomy, RSOright salpingo-oophorectomy, BSObilateral salpingo-oophorectomy, LCyst left cystec-
tomy, C-L corpus luteum, LTFlost to follow-up, SWIsuperficial wound infection, VHvaginal hysterectomy, T/Otube and ovary,
TOAtubo-ovarian abscess, N/A not available, PURpostop urinary retention, Hemhemorrhagic, Hysthysterectomy, CAcancer.
bMass aspirated.
cMass morcellated.
dLong-term follow-up—6 months to 5 years.
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